Biblioteca Humberto Rosselli Quijano
The American Journal of Psychiatry / American Psychiatric Association (1981; Washington, Estados Unidos de América) . Año 2022 Vol. 179 - No. 2Fecha de aparición: 23/03/2022 |
[número]
es un número de The American Journal of Psychiatry / American Psychiatric Association (1981; Washington, Estados Unidos de América)
[número] es un número de The American Journal of Psychiatry / American Psychiatric Association (1981; Washington, Estados Unidos de América) ISSN : 0002953X Idioma : Inglés (eng) Idioma original : Inglés (eng)
|
Ejemplares (1)
Código de barras | Signatura | Tipo de medio | Ubicación | Sección | Estado |
---|---|---|---|---|---|
101668 | The American Journal of Psychiatry | Publicaciones seriadas | Biblioteca Instituto Colombiano del Sistema Nervioso | Hemeroteca | Disponible |
Artículos
Añadir el resultado a su cestaRisks and benefits of cannabis and cannabinoids in psychiatry / Kevin P. Hill en The American Journal of Psychiatry, Año 2022 Vol. 179 - No. 2 (Febrero)
[artículo]
Título : Risks and benefits of cannabis and cannabinoids in psychiatry Tipo de documento: texto impreso Autores: Kevin P. Hill, Autor ; Mark S. Gold, Autor ; Charles B. Nemeroff, Autor Fecha de publicación: 2022 Artículo en la página: pp. 98-109 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Canabis, Cannabinoides, Trastornos adictivos y relacionados con sustancias Resumen: The United States is in the midst of rapidly changing laws regarding cannabis. The increasing availability of cannabis for recreational and medical use requires that mental health clinicians be knowledgeable about evidence to be considered when counseling both patients and colleagues. Link: ./index.php?lvl=notice_display&id=28329
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 98-109[artículo] Risks and benefits of cannabis and cannabinoids in psychiatry [texto impreso] / Kevin P. Hill, Autor ; Mark S. Gold, Autor ; Charles B. Nemeroff, Autor . - 2022 . - pp. 98-109.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 98-109
Palabras clave: Canabis, Cannabinoides, Trastornos adictivos y relacionados con sustancias Resumen: The United States is in the midst of rapidly changing laws regarding cannabis. The increasing availability of cannabis for recreational and medical use requires that mental health clinicians be knowledgeable about evidence to be considered when counseling both patients and colleagues. Link: ./index.php?lvl=notice_display&id=28329 Trends in outpatient psychotherapy provision by U.S. psychiatrists / Daniel Tadmon en The American Journal of Psychiatry, Año 2022 Vol. 179 - No. 2 (Febrero)
[artículo]
Título : Trends in outpatient psychotherapy provision by U.S. psychiatrists : 1996–2016 Tipo de documento: texto impreso Autores: Daniel Tadmon, Autor ; Mark Olfson, Autor Fecha de publicación: 2022 Artículo en la página: pp. 110-121 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Psicoterapia, Psiquiatría ambulatoria Resumen: Previous work has demonstrated significant declines in the provision of outpatient psychotherapy by U.S. psychiatrists. The objective of this study was to characterize patterns and trends of psychotherapy by U.S. psychiatrists from 1996 to 2016. Link: ./index.php?lvl=notice_display&id=28330
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 110-121[artículo] Trends in outpatient psychotherapy provision by U.S. psychiatrists : 1996–2016 [texto impreso] / Daniel Tadmon, Autor ; Mark Olfson, Autor . - 2022 . - pp. 110-121.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 110-121
Palabras clave: Psicoterapia, Psiquiatría ambulatoria Resumen: Previous work has demonstrated significant declines in the provision of outpatient psychotherapy by U.S. psychiatrists. The objective of this study was to characterize patterns and trends of psychotherapy by U.S. psychiatrists from 1996 to 2016. Link: ./index.php?lvl=notice_display&id=28330 Rel-1017 (esmethadone) as adjunctive treatment in patients with major depressive disorder / Maurizio Fava en The American Journal of Psychiatry, Año 2022 Vol. 179 - No. 2 (Febrero)
[artículo]
Título : Rel-1017 (esmethadone) as adjunctive treatment in patients with major depressive disorder : a phase 2a randomized double-blind trial Tipo de documento: texto impreso Autores: Maurizio Fava, Autor ; Stephen M. Stahl, Autor ; Luca Pani, Autor Fecha de publicación: 2022 Artículo en la página: pp. 122-131 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos depresivos, Trastorno depresivo mayor, Neurología Resumen: The purpose of this study was to examine the effects of REL-1017 (esmethadone), a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker, in patients with major depressive disorder who failed to benefit from one to three standard antidepressant treatments in their current major depressive episode. Link: ./index.php?lvl=notice_display&id=28331
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 122-131[artículo] Rel-1017 (esmethadone) as adjunctive treatment in patients with major depressive disorder : a phase 2a randomized double-blind trial [texto impreso] / Maurizio Fava, Autor ; Stephen M. Stahl, Autor ; Luca Pani, Autor . - 2022 . - pp. 122-131.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 122-131
Palabras clave: Trastornos depresivos, Trastorno depresivo mayor, Neurología Resumen: The purpose of this study was to examine the effects of REL-1017 (esmethadone), a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker, in patients with major depressive disorder who failed to benefit from one to three standard antidepressant treatments in their current major depressive episode. Link: ./index.php?lvl=notice_display&id=28331 Stanford neuromodulation therapy (snt) / Eleanor J. Cole en The American Journal of Psychiatry, Año 2022 Vol. 179 - No. 2 (Febrero)
[artículo]
Título : Stanford neuromodulation therapy (snt) : a double blind randomized controlled trial Tipo de documento: texto impreso Autores: Eleanor J. Cole, Autor ; Angela L. Phillips, Autor Fecha de publicación: 2022 Artículo en la página: pp. 132-141 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Estimulación Magnética Transcraneal, Trastorno depresivo mayor, Neuroestimulación, Depresión resistente al tratamiento, Estimulación intermitente Theta-Burst, Neuromodulación. Resumen: Depression is the leading cause of disability worldwide, and half of patients with depression have treatment-resistant depression. Intermittent theta-burst stimulation (iTBS) is approved by the U.S. Food and Drug Administration for the treatment of treatment-resistant depression but is limited by suboptimal efficacy and a 6-week duration. Link: ./index.php?lvl=notice_display&id=28332
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 132-141[artículo] Stanford neuromodulation therapy (snt) : a double blind randomized controlled trial [texto impreso] / Eleanor J. Cole, Autor ; Angela L. Phillips, Autor . - 2022 . - pp. 132-141.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 132-141
Palabras clave: Estimulación Magnética Transcraneal, Trastorno depresivo mayor, Neuroestimulación, Depresión resistente al tratamiento, Estimulación intermitente Theta-Burst, Neuromodulación. Resumen: Depression is the leading cause of disability worldwide, and half of patients with depression have treatment-resistant depression. Intermittent theta-burst stimulation (iTBS) is approved by the U.S. Food and Drug Administration for the treatment of treatment-resistant depression but is limited by suboptimal efficacy and a 6-week duration. Link: ./index.php?lvl=notice_display&id=28332 Variable patterns of remission from adhd in the multimodal treatment study of ADHD / Margaret H. Sibley en The American Journal of Psychiatry, Año 2022 Vol. 179 - No. 2 (Febrero)
[artículo]
Título : Variable patterns of remission from adhd in the multimodal treatment study of ADHD Tipo de documento: texto impreso Autores: Margaret H. Sibley, Autor ; L. Eugene Arnold, Autor ; James M. Swanson, Autor Fecha de publicación: 2022 Artículo en la página: pp. 142-151 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos del neurodesarrollo, TDAH, Descuento, Procesando, Síntomas. Resumen: It is estimated that childhood attention deficit hyperactivity disorder (ADHD) remits by adulthood in approximately 50% of cases; however, this conclusion is typically based on single endpoints, failing to consider longitudinal patterns of ADHD expression. The authors investigated the extent to which children with ADHD experience recovery and variable patterns of remission by adulthood. Link: ./index.php?lvl=notice_display&id=28333
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 142-151[artículo] Variable patterns of remission from adhd in the multimodal treatment study of ADHD [texto impreso] / Margaret H. Sibley, Autor ; L. Eugene Arnold, Autor ; James M. Swanson, Autor . - 2022 . - pp. 142-151.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 142-151
Palabras clave: Trastornos del neurodesarrollo, TDAH, Descuento, Procesando, Síntomas. Resumen: It is estimated that childhood attention deficit hyperactivity disorder (ADHD) remits by adulthood in approximately 50% of cases; however, this conclusion is typically based on single endpoints, failing to consider longitudinal patterns of ADHD expression. The authors investigated the extent to which children with ADHD experience recovery and variable patterns of remission by adulthood. Link: ./index.php?lvl=notice_display&id=28333 Adjunctive ketamine with relapse prevention based psychological therapy in the treatment of alcohol use disorder / Meryem Grabski en The American Journal of Psychiatry, Año 2022 Vol. 179 - No. 2 (Febrero)
[artículo]
Título : Adjunctive ketamine with relapse prevention based psychological therapy in the treatment of alcohol use disorder Tipo de documento: texto impreso Autores: Meryem Grabski, Autor ; Amy McAndrew, Autor ; Will Lawn, Autor Fecha de publicación: 2022 Artículo en la página: pp. 152-162 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos adictivos y relacionados con sustancias, Alcohol, Ketamina/Esketamina, Psicoterapia Resumen: Early evidence suggests that ketamine may be an effective treatment to sustain abstinence from alcohol. The authors investigated the safety and efficacy of ketamine compared with placebo in increasing abstinence in patients with alcohol use disorder. An additional aim was to pilot ketamine combined with mindfulness-based relapse prevention therapy compared with ketamine and alcohol education as a therapy control. Link: ./index.php?lvl=notice_display&id=28334
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 152-162[artículo] Adjunctive ketamine with relapse prevention based psychological therapy in the treatment of alcohol use disorder [texto impreso] / Meryem Grabski, Autor ; Amy McAndrew, Autor ; Will Lawn, Autor . - 2022 . - pp. 152-162.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 152-162
Palabras clave: Trastornos adictivos y relacionados con sustancias, Alcohol, Ketamina/Esketamina, Psicoterapia Resumen: Early evidence suggests that ketamine may be an effective treatment to sustain abstinence from alcohol. The authors investigated the safety and efficacy of ketamine compared with placebo in increasing abstinence in patients with alcohol use disorder. An additional aim was to pilot ketamine combined with mindfulness-based relapse prevention therapy compared with ketamine and alcohol education as a therapy control. Link: ./index.php?lvl=notice_display&id=28334